Quantcast

In-depth analysis of ADHD market

DUBLIN–(BUSINESS WIRE)–The “Global
Attention-Deficit Hyperactivity Disorder (ADHD) Market: Size, Trends and
Forecast (2019-2023)”
report has been added to ResearchAndMarkets.com’s
offering.

Global Attention-Deficit Hyperactivity Disorder (ADHD) Market: Size,
Trends, and Forecast (2019-2023) provides an in-depth analysis of the
ADHD market including a detailed description of market sizing and
growth. The report provides an analysis of the global ADHD market by
value, by segments and by distribution channel. The report also provides
a regional analysis of the ADHD market for the following regions: North
America, Europe, Asia-Pacific, Middle East, and Africa and Latin America.

Moreover, the report also assesses the key opportunities in the market
and outlines the factors that are and will be driving the growth of the
industry. Growth of the overall ADHD market has also been forecasted for
the period 2019-2023, taking into consideration the previous growth
patterns, the growth drivers and the current and future trends.

ADHD has been segmented on the basis of medication type, therapy, age
group, and distribution channel. The two major kinds of medication for
the treatment of ADHD are stimulants and non-stimulants. Various kinds
of therapies for ADHD include behavior therapy, cognitive behavioral
therapy, interpersonal therapy, and family therapy. On the basis of age
group, ADHD has been segmented into pediatric, adolescent and adult and
the major distribution channels for ADHD are retail pharmacy and
hospital pharmacy.

The global attention-deficit hyperactivity disorder (ADHD) market has
witnessed continuous growth in the past few years and is projected to
grow even further during the forecast period (2019-2023). The market is
expected to be driven by various growth enhancing factors such as rising
healthcare expenditure, excessive use of smartphones, increasing
investments in mental health technology, the growing impact of social
media, etc. Some of the major challenges faced by the market are the
misuse of drugs used in the treatment of ADHD and high cost of ADHD
treatment.

The major players dominating the attention-deficit hyperactivity
disorder (ADHD) market are Johnson & Johnson, Pfizer Inc., Eli Lilly and
Company and Takeda Pharmaceutical Company Limited (Shire Plc). The four
companies have been profiled in the report providing their business
overview, financial overview, and business strategies.

Key Topics Covered:

1. Executive Summary

2. Introduction

2.1 Attention-Deficit Hyperactivity Disorder (ADHD): An Overview

2.1.1 Causes of ADHD

2.1.2 Symptoms of ADHD

2.1.3 ADHD Subtypes

2.2 ADHD Treatment: An Overview

2.2.1 ADHD Treatment

2.3 ADHD Segmentation: An Overview

2.3.1 ADHD Segmentation by Medication Type

2.3.2 ADHD Segmentation by Therapy

2.3.3 ADHD Segmentation by Age Group and Distribution Channel

3. Global Market Analysis

3.1 Global ADHD Market: An Analysis

3.1.1 Global ADHD Market by Value

3.1.2 Global ADHD Market by Region (North America, Europe, Asia Pacific,
Middle East and Africa, Latin America)

3.1.3 Global ADHD Market by Segments (Stimulant, Non-Stimulant)

3.1.4 Global ADHD Market by Distribution Channel (Retail Pharmacy,
Hospital Pharmacy)

3.2 Global ADHD Market: Segment Analysis

3.2.1 Global Stimulant ADHD Market by Value

3.2.2 Global Non-Stimulant ADHD Market by Value

3.3 Global ADHD Market: Distribution Channel Analysis

3.3.1 Global Retail Pharmacy ADHD Market by Value

3.3.2 Global Hospital Pharmacy ADHD Market by Value

4. Regional Market Analysis

4.1 North America ADHD Market: An Analysis

4.1.1 North America ADHD Market by Value

4.1.2 North America ADHD Market by Region (The US, North America
(Excluding the US))

4.1.3 The US ADHD Market by Value

4.1.4 The US ADHD Market by Segments (Stimulant and Non-Stimulant)

4.1.5 The US Stimulant ADHD Market by Value

4.1.6 The US Non-Stimulant ADHD Market by Value

4.1.7 North America (Excluding the US) ADHD Market by Value

4.2 Europe ADHD Market: An Analysis

4.2.1 Europe ADHD Market by Value

4.3 Asia-Pacific ADHD Market: An Analysis

4.3.1 Asia-Pacific ADHD Market by Value

4.4 Middle East and Africa ADHD Market: An Analysis

4.4.1 Middle East and Africa ADHD Market by Value

4.5 Latin America ADHD Market: An Analysis

4.5.1 Latin America ADHD Market by Value

5. Market Dynamics

5.1 Growth Drivers

5.1.1 Rising Healthcare Expenditure

5.1.2 Excessive Use of Smartphones

5.1.3 Increasing Investments in Mental Health Technology

5.1.4 Growing Impact of Social Media

5.1.5 Increasing Mental Health Awareness

5.1.6 Stressful Lifestyle

5.2 Challenges

5.2.1 Misuse of Drugs Used in the Treatment of ADHD

5.2.2 High Cost of ADHD Treatment

5.3 Market Trends

5.3.1 Growing Use of Combination Therapy

5.3.2 Rising Demand for Neurofeedback Therapy

5.3.3 Development of New Drugs

6. Competitive Landscape

6.1 Global ADHD Market Players: Financial Comparison

6.2 Global ADHD Market Players by Research and Development Expenditure

7. Company Profiles

  • Eli Lilly and Company
  • Johnson & Johnson
  • Pfizer Inc.
  • Takeda Pharmaceutical Company Limited (Shire Plc)

For more information about this report visit https://www.researchandmarkets.com/r/b904y3

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Mental
Disorders Drugs

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.